|
1
|
Kusachi S, Kashimura N, Konishi T, et al:
Length of stay and cost for surgical site infection after abdominal
and cardiac surgery in Japanese hospitals: multi-center
surveillance. Surg Infect (Larchmt). 13:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mangram AJ, Horan TC, Pearson ML, et al:
Guideline for prevention of surgical site infection, 1999. Hospital
Infection Control Practices Advisory Committee. Infect Control Hosp
Epidemiol. 20:250–280. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takesue Y, Kusunoki M, Kobayashi M, et al:
The prevalence of surgical site infection (SSI) by the introduction
of the best practice in the perioperative management and operative
manipulation; multi-center prospective study of 1601 colorectal
patients. Nihon Geka Kansenshō Gakkai Zasshi. 3:471–476. 2006.
|
|
4
|
Rafter J: The effects of probiotics on
colon cancer development. Nutr Res Rev. 17:277–284. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang T, Cai G, Qiu Y, et al: Structural
segregation of gut microbiota between colorectal cancer patients
and healthy volunteers. ISME J. 6:320–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eguchi S, Takatsuki M, Hidaka M, et al:
Perioperative synbiotic treatment to prevent infectious
complications in patients after elective living donor liver
transplantation: a prospective randomized study. Am J Surg.
201:498–502. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagashima K, Hisada T, Sato M and
Mochizuki J: Application of new primer-enzyme combinations to
terminal restriction fragment length polymorphism profiling of
bacterial populations in human feces. Appl Environ Microbiol.
69:1251–1262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kowalski R, Post D, Schneider MC, et al:
Immune cell function testing: an adjunct to therapeutic drug
monitoring in transplant patient management. Clin Transplant.
17:77–88. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Onodera T, Goseki N and Kosaki G:
Prognostic nutritional index in gastrointestinal surgery of
malnourished cancer patients. Nihon Geka Gakkai Zasshi.
85:1001–1005. 1984.PubMed/NCBI
|
|
10
|
Nakamura T, Kashimura N, Noji T, et al:
Triclosan-coated sutures reduce the incidence of wound infections
and the costs after colorectal surgery: a randomized controlled
trial. Surgery. 153:576–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itani KM, Wilson SE, Awad SS, et al:
Ertapenem versus cefotetan prophylaxis in elective colorectal
surgery. N Engl J Med. 355:2640–2651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Serra-Aracil X, García-Domingo MI, Parés
D, et al: Surgical site infection in elective operations for
colorectal cancer after the application of preventive measures.
Arch Surg. 146:606–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Young H, Knepper B, Moore EE, et al:
Surgical site infection after colon surgery: National Healthcare
Safety Network risk factors and modeled rates compared with
published risk factors and rates. J Am Coll Surg. 214:852–859.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanaka K, Yano M, Motoori M, et al: Impact
of perioperative administration of synbiotics in patients with
esophageal cancer undergoing esophagectomy: a prospective
randomized controlled trial. Surgery. 152:832–842. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugawara G, Nagino M, Nishio H, et al:
Perioperative synbiotic treatment to prevent postoperative
infectious complications in biliary cancer surgery: a randomized
controlled trial. Ann Surg. 244:706–714. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang JW, Du P, Gao J, et al: Preoperative
probiotics decrease postoperative infectious complications of
colorectal cancer. Am J Med Sci. 343:199–205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanazawa H, Nagino M, Kamiya S, et al:
Synbiotics reduce postoperative infectious complications: a
randomized controlled trial in biliary cancer patients undergoing
hepatectomy. Langenbecks Arch Surg. 390:104–113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sheih YH, Chiang BL, Wang LH, et al:
Systemic immunity-enhancing effects in healthy subjects following
dietary consumption of the lactic acid bacterium Lactobacillus
rhamnosus HN001. J Am Coll Nutr. 20(2 Suppl): 149–156. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsuzaki T and Chin J: Modulating immune
responses with probiotic bacteria. Immunol Cell Biol. 78:67–73.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang YF, Liu PY, Chen YY, et al:
Three-combination probiotics therapy in children with salmonella
and rotavirus gastroenteritis. J Clin Gastroenterol. 48:37–42.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bartosch S, Woodmansey EJ, Paterson JC, et
al: Microbiological effects of consuming a synbiotic containing
Bifidobacterium bifidumBifidobacterium lactis, and
oligofructose in elderly persons, determined by real-time
polymerase chain reaction and counting of viable bacteria. Clin
Infect Dis. 40:28–37. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mitsuoka T: Significance of dietary
modulation of intestinal flora and intestinal environment. Biosci
Microflora. 19:15–25. 2000. View Article : Google Scholar
|
|
23
|
Willemsen LE, Koetsier MA, van Deventer SJ
and van Tol EA: Short chain fatty acids stimulate epithelial mucin
2 expression through differential effects on prostaglandin E(1) and
E(2) production by intestinal myofibroblasts. Gut. 52:1442–1447.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kowalski RJ, Post DR, Mannon RB, et al:
Assessing relative risks of infection and rejection: a
meta-analysis using an immune function assay. Transplantation.
82:663–668. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sheeran P and Hall GM: Cytokines in
anaesthesia. Brit J Anaesth. 78:201–219. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duc le H, Hong HA, Barbosa TM, et al:
Characterization of Bacillus probiotics available for human use.
Appl Environ Microbiol. 70:2161–2171. 2004. View Article : Google Scholar : PubMed/NCBI
|
